News Conference News EuroPCR 2025 Short DAPT All That’s Needed With Contemporary DES: HOST-IDEA at 3 Years Yael L. Maxwell June 02, 2025
News Conference News EuroPCR 2025 Short DAPT Safe in ACS With No Ischemic Penalty: 4D-ACS L.A. McKeown May 30, 2025
Presentation EuroPCR 2025 Final seven-year outcome of the COMPARE-ABSORB trial Presenter: Pieter Smits May 22, 2025
News Conference News EuroPCR 2025 Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI Michael O'Riordan May 20, 2025
News Conference News SCAI 2025 Medicare Analysis Reassures on PCI in Ambulatory Surgery Centers L.A. McKeown May 07, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Daily News ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients Michael O'Riordan March 26, 2025
News Daily News The ‘Smoker’s Paradox’ Takes a New Hit From Long-term Analysis Yael L. Maxwell March 24, 2025
News Daily News REVIVED/STICHES Analysis Questions Surgery’s Benefit in Ischemic HF Michael O'Riordan March 11, 2025
News Conference News CRT 2025 AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years L.A. McKeown March 10, 2025
News Daily News Philips Recalls Tack Endovascular Systems and Stops Distribution L.A. McKeown March 03, 2025
News Industry News Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States January 21, 2025
News Daily News BMJ Investigation Revives Questions About PLATO, Ticagrelor Todd Neale December 20, 2024
News Daily News Potential Sex Differences Seen for FFR-Guided PCI vs CABG in FAME 3 Todd Neale December 09, 2024
Presentation Cardiovascular Interventions 2024 AGENT DCB: Device and Data Presenter: Paul S. Teirstein November 11, 2024
Presentation Cardiovascular Interventions 2024 Drug Coated Balloons:Patient Selection, Technique, Outcomes Presenter: Ajay J. Kirtane November 11, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024